|
Allocation concealment by funding source and by trial outcome |
|||||
| Adequate |
Inadequate |
Unclear |
Total |
OR* (95% CI) |
|
|
|
|||||
| By Funding Source: |
|||||
|
|
|||||
| Industry Only |
16 |
1 |
27 |
44 |
1.00 (ref) |
| Not for Profit Only |
13 |
2 |
13 |
28 |
.55 (.21, 1.42) |
| Mixed + |
6 |
1 |
15 |
22 |
1.35 (.46, 3.98) |
| Not Reported |
1 |
1 |
4 |
6 |
1.26 (.21, 7.64) |
| Total |
36 |
5 |
59 |
100 |
|
|
|
|||||
| p = .377 |
|||||
|
|
|||||
| By Direction and Statistical Significance of Trial Outcome: |
|||||
|
|
|||||
| Favoured New |
21 |
4 |
42 |
67 |
1.00 (ref) |
| Favoured Conventional |
4 |
0 |
2 |
6 |
.24 (.04, 1.32) |
| Neutral |
7 |
1 |
11 |
19 |
.82 (.29, 2.31) |
| Unclear |
4 |
0 |
4 |
8 |
.79 (.16, 3.84) |
| Total |
36 |
5 |
59 |
100 |
|
|
|
|||||
| p = .678 |
|||||
|
*OR = odds ratio of unclear allocation concealment, relative to clear (i.e., adequate or inadequate); + = funding by at least one industry source and at least one not-for-profit source | |||||
Clifford et al. BMC Health Services Research 2002 2:18 doi:10.1186/1472-6963-2-18 |
|||||